Evotec (EVO)
(Delayed Data from NSDQ)
$4.71 USD
-0.11 (-2.28%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $4.73 +0.02 (0.42%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth F Momentum D VGM
Price, Consensus and EPS Surprise
EVO 4.71 -0.11(-2.28%)
Will EVO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for EVO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EVO
Evotec (EVO) Inks Drug Discovery Collaboration Deal With J&J
EVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for EVO
Evotec (0IRF) Receives a Buy from RBC Capital
Jefferies Reaffirms Their Buy Rating on Evotec (0IRF)
Evotec’s Promising Outlook: Strong Partnerships and Solid Financials Underpin Buy Rating
Evolve Education Group Sees Shareholding Shift
GLOBAL BROKER RATINGS: MWB raises Kion, DZ Bank cuts Mercedes-Benz